Banco Santander S.A. Sells 7,436 Shares of CVS Health Co. (NYSE:CVS)

Banco Santander S.A. cut its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 11.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 60,031 shares of the pharmacy operator's stock after selling 7,436 shares during the period. Banco Santander S.A.'s holdings in CVS Health were worth $2,695,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of CVS. Hotchkis & Wiley Capital Management LLC grew its holdings in shares of CVS Health by 34.8% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock valued at $748,085,000 after acquiring an additional 3,071,613 shares in the last quarter. Raymond James Financial Inc. bought a new position in CVS Health during the fourth quarter valued at $116,033,000. ARGA Investment Management LP grew its holdings in CVS Health by 7,567.7% during the fourth quarter. ARGA Investment Management LP now owns 2,402,901 shares of the pharmacy operator's stock valued at $107,866,000 after purchasing an additional 2,371,563 shares during the period. State Street Corp grew its holdings in CVS Health by 3.6% during the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock valued at $3,554,475,000 after purchasing an additional 1,989,066 shares during the period. Finally, TOMS Capital Investment Management LP bought a new position in CVS Health during the third quarter valued at $121,987,000. 80.66% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares of the company's stock, valued at $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Michael F. Mahoney acquired 30,000 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were purchased at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their position. The disclosure for this purchase can be found here. 0.24% of the stock is owned by insiders.

Remove Ads

CVS Health Trading Up 1.7 %

Shares of NYSE:CVS traded up $1.09 on Friday, reaching $66.34. 10,082,148 shares of the company traded hands, compared to its average volume of 11,965,158. The business's 50-day simple moving average is $56.42 and its 200 day simple moving average is $56.73. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The stock has a market capitalization of $83.64 billion, a P/E ratio of 18.12, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, equities analysts anticipate that CVS Health Co. will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.01%. CVS Health's payout ratio is presently 72.68%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on CVS shares. StockNews.com raised CVS Health from a "sell" rating to a "hold" rating in a report on Thursday, February 13th. TD Cowen increased their price objective on CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a report on Monday, November 25th. Royal Bank of Canada cut their price target on CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a report on Friday, November 15th. Barclays raised their price target on CVS Health from $71.00 to $73.00 and gave the stock an "overweight" rating in a report on Thursday, February 13th. Finally, Deutsche Bank Aktiengesellschaft raised CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price target for the company in a report on Tuesday, December 3rd. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $69.83.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.